COVAX

Gavi co-led COVAX, the vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A).

OWP logo

About

From 2020 through 2023, COVAX, a global initiative focused on equitable access to COVID-19 vaccines, enabled the largest and fastest public health roll-out in history in the face of an unprecedented global emergency. It helped avert millions of deaths and generated invaluable learnings that underscore how the world must be better prepared for future pandemics.

Click below for COVAX’s impact, history, key learnings and participant perspectives.

About COVAX

Gavi's role in COVAX

COVAX Facility

Managing the end-to-end coordination of COVAX, ensuring pooled procurement and equitable distribution of COVID-19 vaccines around the world.

Gavi COVAX AMC

The Gavi COVAX Advance Market Commitment (AMC) ensured access to COVID-19 vaccines and support for lower-income countries.

COVAX in humanitarian settings

Addressing the most unpredictable and hard-to-fill gaps in access.

Credit: Talukdar David / Shutterstock.com

COVID-19 vaccines FAQ

Now that COVID-19 vaccines have reached billions of people worldwide, the evidence is overwhelming that no matter which one you take, the vaccines offer life-saving protection against a disease that has killed millions.

Learn more

Latest news

Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement

Novavax, Inc. (Nasdaq: NVAX) and Gavi, the Vaccine Alliance (Gavi) today announced they have reached a settlement related to the 2021 Advance Purchase Agreement (APA) for Novavax’s prototype COVID-19 vaccine (NVX-CoV2373). This agreement brings…

COVID-19 vaccinations shift to regular immunisation as COVAX draws to a close

COVAX will close 31 December 2023 having delivered nearly 2 billion doses of vaccines to 146 economies, and averted an estimated 2.7 million deaths in AMC lower-income participating economies.

Gavi, Moderna update COVAX supply agreement; agree on access to variant-containing vaccines for lower-income countries

Gavi and Moderna agree to cancel remaining volumes under existing COVAX supply agreement.

Call for Applications: COVAX seeks experts for independent group on evidence-based vaccine decision-making

The COVAX Facility is seeking expressions of interest from the subject matter experts to join the COVAX Independent Product Group. The Independent Product Group (“IPG”) is established to provide scientific advice on COVID-19 vaccines and…

Gavi board responds to an uncertain world: fragile and conflict settings, future pandemics and the ongoing fight against COVID-19

Gavi’s Board Meeting emphasizes public health impact with renewed push for routine immunization and reaching zero-dose children.

COVAX calls for urgent action to close vaccine equity gap

COVAX has access to enough COVID-19 vaccines to help protect 70% of the population in 91 lower-income countries

DFC financing up to US$ 1 billion for Gavi COVID-19 vaccine and ancillary supply purchase and delivery

The White House today announced that US International Development Finance Corporation (DFC) and Gavi, the Vaccine Alliance have partnered to create the COVAX Rapid Financing Facility, which will provide up to US$ 1 billion to accelerate COVID-19…

World leaders commit US$ 4.8 billion to help Break COVID Now

Summit sees US$ 4.8 billion in commitments, securing vital cash to help lower income countries boost vaccinations now, secure equitable access for new vaccine procurements plus additional help for countries looking to procure their own vaccines…

New Gavi Risk Sharing Partnership with MedAccess and the Open Society Foundations to help meet country demand for COVID-19 vaccines

This new partnership comes as Gavi seeks to raise additional funds to support COVAX. April 8 will see Germany, Indonesia and Senegal co-host the 2022 Gavi COVAX AMC Summit, where governments, international organisations, civil society and the…

Indonesia and Senegal to co-host 2022 Gavi COVAX AMC Summit, together with Germany

The governments holding the presidencies of the G7, the G20 and the African Union will co-host a summit to raise new urgent funding for global vaccination in lower-income economies, a sign of renewed international cooperation and a continued…

Germany to co-host 2022 Gavi COVAX AMC Summit, pledges additional funding for COVID-19 vaccination in lower-income countries

Germany will co-host the 2022 AMC Summit to help raise urgent funding to support lower-income countries’ dynamic COVID-19 vaccination needs.

COVAX crosses milestone of 500 million donated doses shipped to 105 countries

31 countries have contributed to the effort, which accounts for nearly half of COVAX’s total shipments of over 1.1 billion doses – of which more than a billion have been distributed to lower-income economies supported through the Gavi Advance…

World leaders launch call for renewed support for vaccination in 2022 as part of the global fight against COVID-19

COVAX, the vaccine pillar of the Access to COVID-19 Tools Accelerator (ACT-Accelerator), has now shipped over 1 billion doses to 144 countries and territories.

COVAX awarded 2021 North-South Prize for enhancing global equitable access to COVID-19 vaccines

Geneva, 21 December 2021 – The COVAX Facility has been awarded the 2021 North-South Prize of the Council of Europe in recognition of its efforts to ensure that COVID-19 vaccines are available worldwide, including in low-income countries, and for…

Gavi and Moderna reach agreement for additional supply to COVAX

Agreement will make up to an additional 150 million doses of the Moderna COVID-19 vaccine available to COVAX Facility participants in Q2 and Q3 2022, at the lowest tiered price.

Gavi Board approves malaria vaccine programme funding, COVAX 2022 strategic approach and measures to maintain, restore and strengthen routine immunisation

A new malaria vaccination programme has been approved, providing Gavi-eligible countries in sub-Saharan Africa a powerful new tool with which to fight malaria.

New Zealand kicks off 2022 COVAX fundraising efforts with NZ$ 9 million funding pledge

One of the first COVAX funders and first dose donors, New Zealand has again stepped up and pledged NZ$ 9 million in funding to the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC). This funding will help COVAX better respond to country needs…

Joint Statement on Dose Donations of COVID-19 Vaccines to African Countries

Building on lessons learned from our collective experience with dose donations over the past several months, the African Vaccine Acquisition Trust (AVAT), the Africa Centres for Disease Control and Prevention (Africa CDC) and COVAX wish to draw…

Team Europe dose-sharing: nine additional EU member-states support lower-income countries through COVAX

As part of a pledge of 500 million doses by Team Europe, eight EU Member States have donated doses of the AstraZeneca, Johnson & Johnson and Pfizer vaccines to COVAX to support lower-income economies around the world in the fight against the…

Gavi and Switzerland collaborate to prioritise supply to COVAX

Switzerland becomes first country to respond to call to trade places with COVAX in manufacturers’ supply queues.

Team Europe vaccine sharing: almost 100 million J & J doses to be donated by the end of 2021 – first doses arriving in African countries this week

The first shipments of almost 100 million doses of the Johnson & Johnson vaccine from Team Europe are arriving in a number of African countries. This donation is facilitated by a tripartite agreement between Belgium (acting on behalf of Team…

Luxembourg stands up for equitable access by donating doses to COVAX – first doses reach Rwanda

As part of a 409,600-dose pledge to COVAX, Rwanda has become the first country to receive COVID-19 vaccines donated by Luxembourg, receiving 12,000 doses of the AstraZeneca vaccine. This commitment is part of a Team Europe pledge to donate 500…

Gavi and humanitarian agencies partner to deliver COVID-19 vaccines to the most vulnerable people in the world

Geneva/New York, 16 November 2021 – Gavi, the Vaccine Alliance (Gavi) and the member agencies of the Inter-Agency Standing Committee (IASC) the humanitarian system’s main coordinating body1, are working together to ensure that the most vulnerable…

First Greek COVAX doses arrive in Kenya and Syria

The first shipments of a 3 million dose pledge to COVAX thus far by Greece have arrived in Kenya (376,800 doses) and Syria (144,000). This builds on previous funding commitments of EUR 1.5 million to the Gavi COVAX Advance Market Commitment (Gavi…

Finnish COVAX donation kicks off with shipment to Côte d’Ivoire

As part of a pledge to share at least 3.65 million doses of COVID-19 vaccines with lower-income economies through COVAX, Finland’s donation has begun with a first delivery of 98,400 doses of the AstraZeneca vaccine to Côte d’Ivoire.

First Portuguese COVAX doses reach Senegal

As part of a pledge to share at least 5% of domestic supply of vaccines with its development partners, the first doses donated by Portugal through COVAX have reached Senegal.

Vigne des Nations: 2020 vintage awarded to Gavi by Geneva Canton, for its action for global health

This Monday morning, 11 October, Mr Serge Dal Busco, President of the Council of State of Geneva, symbolically awarded the parcel of the Vigne des Nations to Gavi, the Vaccine Alliance. This recognition honours the commitment of this organisation…

First Swiss-donated doses ship to Sierra Leone, as part of 4 million dose pledge

The first shipment of a Swiss donation of 4 million doses has arrived in Sierra Leone, with 24,000 doses of the AstraZeneca vaccine touching down in Freetown on 9 October 2021.

Gulf countries unite to support COVAX

Gulf Cooperation Council (GCC) countries have come together to support global equitable access to COVID-19 vaccines, with pledges now totalling US$ 221 million in funding pledges and US$ 50 million in in-kind support from all six Member States,…

Gavi Board meets to discuss routine immunisation, COVAX’s 2022 strategy

The Gavi Board met yesterday to discuss the impact of the pandemic on routine immunisation and how COVAX can best support countries’ efforts to control the pandemic, as part of a broader consultative process to develop the 2022 COVAX strategy

Global leaders commit further support for global equitable access to COVID-19 vaccines and COVAX

Leaders pledge financing, dose donations, support for country readiness and delivery and scale up of global manufacturing, to enable equitable access to COVID-19 vaccines.

DFC and Citi Risk Management Solution Helps Gavi Strengthen the Foundations of the COVAX Facility

U.S. International Development Finance Corporation, in conjunction with Citi, launch risk management solution for COVAX Facility.

Iceland renews commitment to global equitable access to vaccines: first doses arrive in Côte d’Ivoire

As part of a donation of 125,726 doses to COVAX, the first shipment of 35,700 doses of the AstraZeneca vaccine donated by Iceland has arrived in Côte d’Ivoire.

Iraq receives first doses donated by Italy through COVAX

As part of its pledge to deliver 15 million doses of COVID-19 vaccines, the first doses donated by Italy have been delivered to Iraq, with more shipping to additional countries in the coming days.

First delivery of German-donated COVID vaccines to COVAX land in Mauritania, with other deliveries to follow

Building on its pledge of EUR 1.62 billion to COVAX, the German government has donated the first batch of its pledge of 100 million doses of COVID-19 vaccines, the majority of which will be delivered via COVAX. 

Joint COVAX statement on Supply Forecast for 2021 and early 2022

COVAX has already achieved significant progress: more than US$10 billion has been raised; legally-binding commitments for up to 4.5 billion doses of vaccine; 240 million doses have been delivered to 139 countries in just six months.

First doses donated by Belgium through COVAX arrive to Armenia

As part of its pledge to deliver 4 million doses of COVID-19 vaccines, the first doses donated by Belgium have been delivered to Armenia.

Canada donates doses through COVAX – Nigeria, Kenya and Niger to receive first doses

Three countries in Africa will receive the first Canadian-donated doses of the AstraZeneca vaccine – Nigeria (801,600 doses), Kenya (459,300) and Niger (100,800) – as part of an overall Canadian pledge of over 40 million doses to COVAX

France donates 10 million doses to Africa through COVAX and AU

African Union Member States are to receive an additional 10 million doses of Astra Zeneca and Pfizer COVID-19 vaccines through COVAX and the Africa Vaccine Acquisition Trust (AVAT), thanks to a new arrangement with the French government and the…

First Danish doses delivered through COVAX arrive in Algeria

The first deliveries from a pledge of 1 million doses to be donated to COVAX by Denmark have arrived, with 57,600 doses of the AstraZeneca (AZ) vaccine to Algeria on 26 August.

UK-donated COVID-19 vaccine doses reach African countries

The first AstraZeneca doses donated to COVAX by the United Kingdom (UK) will soon arrive in Angola, Egypt, Ethiopia, Ghana, Kenya, Malawi, Nigeria, Senegal and Uganda, with Zambia and DRC set to be the first to receive these UK-donated vaccines…

China pledges US$ 100 million towards equitable access to COVID-19 vaccines for lower-income countries

The Government of the People’s Republic of China (China) has pledged US$100 million to the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC). The announcement, made at the International Forum on COVID-19 Vaccine Cooperation, hosted by China,…

First doses donated by Spain through COVAX arrive to Peru, Guatemala, Paraguay and Nicaragua

As part of its pledge to deliver 22.5 million doses of COVID-19 vaccines, the first doses donated by Spain are arriving to countries in Latin America.

New financing agreement boost for malaria vaccine

Gavi, MedAccess and GlaxoSmithKline join forces to guarantee continued production of the RTS,S antigen for the RTS,S/AS01e malaria vaccine.

First Swedish doses delivered through COVAX

As part of a pledge to deliver at least three million doses of COVID-19 vaccines, the first doses donated by Sweden have been delivered to countries this week, with shipments arriving in Kyrgyzstan and Afghanistan

First deliveries of Norway-donated COVID-19 vaccines to COVAX

Norway donates first doses to COVAX, with first shipments arriving in Nicaragua and Uganda on 30 July. In total, Norway has pledged 5 million doses to COVAX, as well as US$ 141 million in funding.

COVAX and World Bank to Accelerate Vaccine Access for Developing Countries

COVAX and the World Bank will accelerate COVID-19 vaccine supply for developing countries through a new financing mechanism that builds on Gavi’s newly designed AMC cost-sharing arrangement. This allows AMC countries to purchase doses beyond the…

First doses donated by Japan to COVAX reach lower-income countries

The first COVID-19 vaccine doses donated by Japan to the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC) have been shipped, with first shipments set to arrive in Cambodia and Iran on Friday, 23 July, and Bangladesh on Saturday, 24 July.

US-donated vaccine deliveries to Africa set to begin, with first deliveries planned to Burkina Faso, Djibouti, and Ethiopia

16 July 2021 – Following close collaboration between the African Union (AU)/ African Vaccine Acquisition Trust (AVAT), COVAX and the United States Government, AU Member States are set to receive approximately 25 million COVID-19 vaccines to…

Gavi signs agreements with Sinopharm and Sinovac for immediate supply to COVAX

Gavi, the Vaccine Alliance announced today that it had signed advance purchase agreements (APAs) with Sinopharm for its “BBIBP-CorV” inactivated virus vaccine against COVID-19 as well as with Sinovac for its inactivated virus vaccine against…

Joint COVAX Statement on the equal recognition of vaccines

Geneva/New York/Oslo, 01 July 2021 – COVAX was built on the principle of equitable access to COVID-19 vaccines to protect the health of people all across the globe. That means protecting their lives and livelihoods, including their ability to…

Gavi signs agreement with Clover Biopharmaceuticals for supply to COVAX

Geneva, 30 June 2021 – Gavi, the Vaccine Alliance announced today that it had signed an advance purchase agreement (APA) with Clover Biopharmaceuticals for its SCB-2019 protein-based adjuvanted vaccine candidate against COVID-19. The agreement…

US-donated vaccine deliveries through COVAX set to begin, with first shipment to Honduras

Geneva, 27 June 2021 – Following announcements in recent weeks of donation pledges by the Biden-Harris Administration, COVAX is preparing to ship doses of COVID-19 vaccines donated to COVAX by the United States Government to protect at-risk…

What does COVAX’s latest supply forecast tell us?

The forecast is encouraging given the supply disruptions COVAX and countries with bilateral deals are currently experiencing, and the general challenges manufacturers are experiencing as they ramp up supply at historic speed and scale.

Republic of Korea pledges US$ 200 million to support lower-income economies through Gavi COVAX Advance Market Commitment

The Republic of Korea has announced a pledge of US$ 200 million to the Gavi COVAX Advance Commitment (Gavi COVAX AMC), with US$ 100 million to be provided in 2021 and an additional US$ 100 million to be provided in 2022

G7 announces pledges of 870 million COVID-19 vaccine doses, of which at least half to be delivered by the end of 2021

COVAX welcomes dose sharing commitments for 870 million additional doses to support equitable access to vaccines in 2021 and 2022, with the aim to deliver at least half by the end of 2021.

Gavi welcomes U.S. decision to procure 500 million vaccine doses to be delivered through COVAX

Geneva, 10 June 2021 – Gavi, the Vaccine Alliance, today welcomes the decision by the United States Government to procure 500 million COVID-19 vaccine doses on behalf of the COVAX Facility.

Gavi welcomes U.S. allocation plan for vaccine dose-sharing – 19 million doses donated to COVAX in first tranche

Gavi, the Vaccine Alliance, welcomes the announcement by the United States Government of its strategy for global vaccine sharing, which sets out how it will provide at least 80 million doses of vaccines to the rest of the world – with the…

World leaders unite to commit to global equitable access for COVID-19 vaccines

The Gavi COVAX AMC Summit “One World Protected” virtual event, hosted today by the Government of Japan and Gavi, the Vaccine Alliance, raised US$ 2.4 billion from nearly 40 donor governments, the private sector and foundations, exceeding the…

New Zealand transfers vaccine doses to COVAX – 6 Pacific nations first to benefit

Responding to an urgent need for doses around the world, the Government of New Zealand has pledged to transfer 1.6 million doses allocated through COVAX to lower-income economies.

Call to action to equip COVAX to deliver 2 billion doses in 2021

Countries that are advanced in their vaccination programmes are seeing cases of COVID-19 decline, hospitalisations decrease and early signs of some kind of normality resume. However, the global picture is far more concerning.

Global leaders renew their commitment to address urgency of COVID-19 pandemic

At today’s Global Health Summit, hosted by the European Commission and Italy as chair of the G20, leaders pledged their support to the Gavi COVAX Advance Market Commitment (AMC).

Gavi signs agreement with Johnson & Johnson for supply of its COVID-19 vaccine to COVAX

The signed advance purchase agreement (APA) is for a commitment to purchase 200 million doses of the Johnson & Johnson vaccine, with the goal of them being made available to the COVAX Facility in 2021.

Go Give One campaign gives public the opportunity to support access to COVID-19 vaccines for lower-income countries

Individuals can now directly fund vaccines for lower-income countries via the Gavi COVAX AMC to help end the pandemic. The platform will give businesses a chance to match employee and customer contributions.

Japan to host Gavi's COVAX Advance Market Commitment (AMC) Summit

Geneva, 12 May 2021 – The Government of Japan yesterday announced that it will host the virtual Gavi COVAX Advance Market Commitment (AMC) Summit on June 2nd 2021. The event, co-hosted by Japanese Prime Minister H.E.

Corporations, charities and governments step up support for equitable COVID-19 vaccine access at Vax Live concert

The pledges were announced at Global Citizen’s Vax Live Concert on Saturday, co-hosted by Selena Gomez and featuring messages from Prince Harry, the Duke of Sussex, His Holiness Pope Francis and several Heads of State

Gavi signs agreement with Novavax to secure doses on behalf of COVAX Facility

The signed advance purchase agreement (APA) is for a commitment to purchase 350 million doses of the Novavax vaccine candidate. Deliveries will commence in Q3 2021, upon regulatory approval.

Gavi signs agreement with Moderna to secure doses on behalf of COVAX Facility

The signed advance purchase agreement (APA) is for up to 500 million doses of the COVID-19 vaccine manufactured by Moderna. Supply via the agreement will take place from the second half of 2021 through 2022, with options in place to address the…

Immunization services begin slow recovery from COVID-19 disruptions, though millions of children remain at risk from deadly diseases

Geneva/New York, 26 April 2021 – While immunization services have started to recover from disruptions caused by COVID-19, millions of children remain vulnerable to deadly diseases, the World Health Organization (WHO), UNICEF and Gavi, the Vaccine…

France makes important vaccine dose donation to COVAX

Today, to mark the first year of the creation of the Access to COVID-19 Tools (ACT) Accelerator, President Emmanuel Macron announced that France has begun sharing vaccine doses with COVAX, starting with a first batch of 105,600 doses – with 500,…

Global leaders rally to accelerate access to COVID-19 vaccines for lower-income countries

The “One World Protected” Event, hosted today by the United States and Gavi, the Vaccine Alliance, launched a campaign to raise US$ 2 billion for the global fight against COVID-19.

COVAX reaches over 100 economies, 42 days after first international delivery

The COVAX Facility has now delivered life-saving vaccines to over 100 economies since making its first international delivery to Ghana on February 24th.

Gavi and Save the Children form global partnership to immunise zero-dose and vulnerable children

The partnership will focus on reaching children who are currently receiving no routine vaccines and marginalised communities in line with Gavi’s vision to ‘leave no-one behind with immunisation’.

United States to host launch event for Gavi COVAX AMC 2021 investment opportunity

The virtual event will bring together world leaders, the private sector, civil society, and key technical partners to galvanize resources and commitment to the Gavi COVAX Advance Market Commitment (AMC).

COVAX updates participants on delivery delays for vaccines from Serum Institute of India (SII) and AstraZeneca

The COVAX Facility has notified participating economies that deliveries of doses from the Serum Institute of India (SII) will be delayed in March and April.

COVAX publishes first round of allocations

Geneva/Oslo/New York, 2 March 2021 – The Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance (Gavi) and the World Health Organization (WHO), as co-leads of the COVAX initiative for equitable global access to COVID-…

First COVID-19 COVAX vaccine doses administered in Africa

Today, the governments of Côte d’Ivoire and Ghana began COVID-19 vaccination campaigns aimed at protecting healthcare workers

COVID-19 vaccine doses shipped by the COVAX Facility head to Ghana, marking beginning of global roll-out

COVAX announces 600,000 doses of the AstraZeneca/Oxford vaccine licensed to Serum Institute of India have arrived in Accra, Ghana; further deliveries to Abidjan, Cote d’Ivoire are expected this week.

No-fault compensation programme for COVID-19 vaccines is a world first

New programme makes compensation available to eligible individuals in 92 low- and middle-income countries without need to resort to law courts.

G7 backs Gavi's COVAX Advance Market Commitment to boost COVID-19 vaccines in world’s poorest countries

Today G7 leaders announced a doubling of funding for Gavi COVAX AMC to support lower-income economies obtain life-saving vaccines against COVID-19, ensuring greater equity in fighting to end the acute phase of the pandemic.

Gavi signs memorandum of understanding with Novavax on behalf of COVAX Facility

The signed memorandum of understanding (MoU) between Gavi and Novavax is to make a cumulative volume of 1.1 billion doses of the Novavax vaccine candidate available to the COVAX Facility.

COVAX Statement on WHO Emergency Use Listing for AstraZeneca/Oxford COVID-19 Vaccine

Geneva / New York / Oslo – 15 February 2021 The Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance (Gavi) and the World Health Organisation (WHO), as co-leads of the COVAX initiative for equitable global access to…

COVAX Statement on New Variants of SARS-CoV-2

The emergence of variants of SARS-CoV-2, the virus that causes COVID-19, serve as a powerful reminder that viruses by their very nature mutate, and that the scientific response may need to adapt if they are to remain effective against them.

COVAX publishes first interim distribution forecast

Geneva/Oslo/New York, 3 February 2021 – The Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance and the World Health Organisation, as co-leads of the COVAX initiative for equitable global access to COVID-19 vaccines…

COVAX announces new agreement, plans for first deliveries

COVAX announced the signing of an advance purchase agreement for up to 40 million doses of the Pfizer-BioNTech vaccine; rollout to commence with successful execution of supply agreements.

COVAX announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021

COVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donors.

Gavi Board approves new push to reach unvaccinated children worldwide

Gavi Board approves more than US$ 600 million in new funding to help accelerate efforts to reach ‘zero-dose’ and under-immunised children in the face of the COVID-19 pandemic.

Team Europe contributes €500 million to COVAX initiative to provide one billion COVID-19 vaccine doses for low- and middle-income countries

High-risk and vulnerable groups and healthcare workers first in line for successful vaccine.

Gavi and IOM join forces to improve immunisation coverage for migrants

Memorandum of understanding signed today will strengthen collaboration on vaccination efforts and related health services for migrants and forcibly displaced persons across the world

Gavi statement on AstraZeneca/Oxford interim efficacy data

Geneva, 24 November 2020 – Gavi, the Vaccine Alliance, as co-lead of COVAX and administrator of the COVAX Facility, welcomes the release of interim efficacy data for the AstraZeneca/Oxford COVID-19 vaccine candidate.

COVAX Facility convenes first meeting of COVAX AMC engagement group

The COVAX AMC Engagement Group, composed of Gavi COVAX AMC participants, donors, and other stakeholders, forms a key component of Facility governance.

Over US$ 2 billion raised to support equitable access to COVID vaccines with additional US$ 5 billion needed in 2021

The European Commission, France, Spain, The Republic of Korea and the Bill & Melinda Gates Foundation pledge US$ 360 million to Gavi’s COVID-19 Vaccines Advance Market Commitment (COVAX AMC)

COVAX Facility convenes first meeting of COVAX Shareholders Council

The COVAX Shareholders Council, composed of all self-financing participants, forms a key component of Facility governance.

COVAX welcomes appointment of civil society representatives

As part of the global response to the COVID-19 pandemic, COVAX – the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, co-led by Gavi, CEPI, and the WHO – welcomes the appointment of civil society organisation representatives to…

Gavi signs statement of intent to procure 200 million doses of Sanofi-GSK COVID-19 vaccine candidate for the COVAX Facility

Gavi, the Vaccine Alliance announced today that it had signed a Statement of Intent with Sanofi and GSK to provide 200 million doses of the companies’ adjuvanted recombinant protein COVID-19 vaccine to the COVAX Facility.

Japan pledges US$ 130 million to support global access to COVID-19 vaccines

Japanese Government pledges US$ 130 million in funding to the Gavi COVAX Advance Market Commitment (AMC), bringing the total raised to roughly US$ 1.8 billion.

Countries pledge nearly US$ 1 billion to support equitable access to COVID-19 vaccines

The United Kingdom, Canada, Germany, Italy and Sweden pledge approximately US$ 960 million to Gavi’s COVID-19 Vaccines Advance Market Commitment (COVAX AMC)

Gavi to provide US$ 150 million to support low- and middle-income countries’ readiness to deliver COVID-19 vaccines

The Gavi Board has approved the provision of US$ 150 million in initial funding to jumpstart support COVAX AMC-eligible countries’ readiness to deliver COVID-19 vaccines, in the form of planning, technical assistance and cold chain equipment

New collaboration makes further 100 million doses of COVID-19 vaccine available to low- and middle-income countries

Collaboration among the Serum Institute of India (SII), Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation will accelerate manufacturing and delivery of up to an additional 100 million doses of future vaccines, if proven to be…

Boost for global response to COVID-19 as economies worldwide formally sign up to COVAX Facility

64 higher income economies have now joined the COVAX Facility, with a further 38 economies expected to sign in the coming days

Australia commits AU$ 80 million to guarantee access to COVID-19 vaccines for all

The funding will support the Gavi COVAX Advance Market Commitment (AMC), which aims to secure doses of COVID-19 vaccines for 92 low- and middle-income countries and economies at the same time as wealthier nations

172 countries & multiple candidate vaccines engaged in COVID-19 Vaccine Global Access Facility

Goal of bringing the pandemic under control via equitable access to COVID-19 vaccines needs urgent, broadscale commitment and investment from countries

Call for applications: COVAX seeks civil society representatives to contribute to ensuring equitable global access to COVID-19 vaccines

CSOs will play a vital role in the development and implementation of the COVAX initiative as well as the deployment of any successful vaccine through COVAX.

Up to 100 million COVID-19 vaccine doses to be made available for low- and middle-income countries as early as 2021

New landmark collaboration between the Serum Institute of India (SII), Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation to accelerate manufacturing and delivery of up to 100 million doses of future safe and effective COVID-…

92 low- and middle-income economies eligible to get access to COVID-19 vaccines through Gavi COVAX AMC

Gavi Board agrees scope of COVAX Advance Market Commitment (AMC), which aims to secure doses of COVID-19 vaccines for 92 low- and middle-income countries and economies at the same time as wealthier nations.

More than 150 countries engaged in COVID-19 vaccine global access facility

Seventy-five countries submit expressions of interest to COVAX Facility, joining up to 90 further countries which could be supported by the COVAX Advance Market Commitment (AMC)

New private sector commitments to fund access to future COVID-19 vaccines announced at international pledging summit

Global technology company TransferWise and a donor which asked to remain anonymous made significant financial commitments to Gavi’s Advance Market Commitment for COVID-19 Vaccines (Gavi COVAX AMC)

Gavi Board calls for global access to COVID-19 vaccines

Gavi Board shows support for continued work on COVAX Facility: a global, coordinated mechanism designed to ensure rapid and equitable access to safe and efficacious COVID-19 vaccines to as broad a global population as possible

Gavi launches innovative financing mechanism for access to COVID-19 vaccines

Gavi Advance Market Commitment for COVID-19 Vaccines (Gavi Covax AMC) launched at Global Vaccine Summit 2020 draws strong support, early commitments from global leaders.

Explore COVAX

About COVAX

A historic multilateral effort co-led by Gavi, CEPI, WHO and UNICEF from 2020 through 2023, COVAX pushed to centre vaccine equity at the heart of the global response to the COVID-19 pandemic. COVAX will come to a close on 31 December 2023.

COVAX Facility

Managing the end-to-end coordination of COVAX, ensuring pooled procurement and equitable distribution of COVID-19 vaccines around the world.

Gavi COVAX AMC

The Gavi COVAX Advance Market Commitment (AMC) ensured access to COVID-19 vaccines and support for lower-income countries.

COVAX in humanitarian settings

Addressing the most unpredictable and hard-to-fill gaps in access.

Last updated: 15 Jan 2024

Subscribe to our newsletter